Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period

被引：69

作者：

Iwai, K

Tashima, M

Itoh, M

Okazaki, T

Yamamoto, K

Ohno, H

Marusawa, H

Ueda, Y

Nakamura, T

Chiba, T

Uchiyama, T

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Hematol Oncol, Sakyo Ku, Kyoto 6068397, Japan

[2] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068397, Japan

[3] Kyoto Univ, Grad Sch Med, Dept Clin Sci Pathol Organs, Kyoto 6068397, Japan

来源：

BONE MARROW TRANSPLANTATION | 2000年 / 25卷 / 01期

关键词：

bone marrow transplantation; hepatitis B; HBsAg-negative;

D O I：

10.1038/sj.bmt.1702093

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

It is widely accepted that seroconversion of HBsAg to HBsAb indicates clearance of hepatitis B virus. We describe a 50-year-old man with chronic myelocytic leukemia who developed lethal hepatitis B 22 months after allo-BMT. He had been negative for HBsAg and positive for HBsAb before BMT. Hepatitis B virus latently existing in the liver cells before BMT proliferated during the immunosuppressed period causing fatal hepatitis. Recipients with positive HBsAb should be considered to have the potential for active hepatitis B to emerge after BMT.

引用

收藏

页码：105 / 108

页数：4

相关论文

共 14 条

[1] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[2]

Brown P, 1987, Asia Pac J Public Health, V1, P62, DOI 10.1177/101053958700100310

[3] Hepatitis B associated liver failure following bone marrow transplantation [J].

Caselitz, M ;

Link, H ;

Hein, R ;

Maschek, H ;

Boker, K ;

Poliwoda, H ;

Manns, MP .

JOURNAL OF HEPATOLOGY, 1997, 27 (03) :572-577

[4]

Dhédin N, 1998, TRANSPLANTATION, V66, P616

[5] INHIBITION OF THE REPLICATION OF HEPATITIS-B VIRUS INVITRO BY 2',3'-DIDEOXY-3'-THIACYTIDINE AND RELATED ANALOGS [J].

DOONG, SL ;

TSAI, CH ;

SCHINAZI, RF ;

LIOTTA, DC ;

CHENG, YC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8495-8499

[6]

MARTIN BA, 1995, BONE MARROW TRANSPL, V15, P145

[7] Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen [J].

Mason, AL ;

Xu, LZ ;

Guo, LS ;

Kuhns, M ;

Perrillo, RP .

HEPATOLOGY, 1998, 27 (06) :1736-1742

[8] FATAL REACTIVATION OF PRECORE MUTANT HEPATITIS-B VIRUS-ASSOCIATED WITH FIBROSING CHOLESTATIC HEPATITIS AFTER BONE-MARROW TRANSPLANTATION [J].

MCIVOR, C ;

MORTON, J ;

BRYANT, A ;

COOKSLEY, WG ;

DURRANT, S ;

WALKER, N .

ANNALS OF INTERNAL MEDICINE, 1994, 121 (04) :274-275

[9] Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: Clinical course and possible treatment with ganciclovir [J].

Mertens, T ;

Kock, J ;

Hampl, W ;

Schlicht, HJ ;

Tillmann, HL ;

Oldhafer, KJ ;

Manns, MP ;

Arnold, R .

JOURNAL OF HEPATOLOGY, 1996, 25 (06) :968-971

[10] FULMINANT-HEPATITIS DUE TO REACTIVATION OF CHRONIC HEPATITIS-B VIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

PARIENTE, EA ;

GOUDEAU, A ;

DUBOIS, F ;

DEGOTT, C ;

GLUCKMAN, E ;

DEVERGIE, A ;

BRECHOT, C ;

SCHENMETZLER, C ;

BERNUAU, J .

DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (09) :1185-1191